Off-Label Drugs: Initial Results of a National Survey: PEMD-91-12BR

Pursuant to a congressional request, GAO provided information about its survey of a nationally representative sample of oncologists to determine the extent to which health insurers denied patients reimbursement for off-label drug use, focusing on: (1) the prevalence of off-label drug use, and how its use varied by clinical, demographic, and geographic factors; (2) the extent to which third-party payers denied payment for such use; and (3) whether third-party payers' policies influenced the treatment of cancer patients.

GAO presented a copy of the questionnaire it mailed to the random sample of oncologists, with the number or percentage of respondents answering each item. GAO noted that it received a 56-percent response rate to its mailing of 1,470 questionnaires.

• Format: Paperback
• Language: English
• ISBN: 1289057397
• ISBN13: 9781289057398
• Release Date: June 2013
• Publisher: Bibliogov
• Length: 36 Pages
• Weight: 0.18 lbs.
• Dimensions: 0.1" x 7.4" x 9.7"